SMO-SHH signaling pathway has been investigated for therapeutic interventions to treat neurocomplications of AD (Prajapati et al., 2023), and W. Ma et al. (2018) also found it to modulate Aβ toxicity in neuroinflammation and cognition in AD. Here, SHH is linked to Alzheimer disease.